Clinical concepts for cabazitaxel in the management of metastatic castration‐resistant prostate cancer
Author:
Affiliation:
1. Department of Medical Oncology and Clinical Trials, Faculty of Medicine and Health SciencesMacquarie University NSW Australia
2. Crown Princess Mary Cancer CentreWestmead Hospital NSW Australia
Publisher
Wiley
Subject
Oncology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13193
Reference46 articles.
1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
2. Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
3. Characterising the castration-resistant prostate cancer population: a systematic review
4. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
5. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fabrication of co-delivery liposomal formulation incorporating carmustine and cabazitaxel displays improved cytotoxic potential and induced apoptosis in ovarian cancer cells;Journal of Biomaterials Science, Polymer Edition;2024-08-29
2. Fabrication of hyaluronic acid-altered gold complex delivery for head and neck squamous cell carcinoma therapy with high antitumor efficacy and low in vivo toxicity;Journal of Photochemistry and Photobiology B: Biology;2024-04
3. Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p‐STAT3 in prostate cancer;The Prostate;2023-10-12
4. Molecular Aspects and Therapeutic Implications of Herbal Compounds Targeting Different Types of Cancer;Molecules;2023-01-11
5. Nanoparticles mediated target-specific drug delivery in prostate cancer: In-depth review;Current Medicinal Chemistry;2021-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3